.gif)
_web.gif)
Table of Contents
Contents
| Contents | |
| 1139-1140 |
From the Editor
| 2020 and all that | |
| B Farham | 1141 |
| Thank you from SAMA and the editors | |
| B Farham | 1142-1143 |
Guest Editorial
| Colonoscopy practice in South Africa: The way forward | |
| L Katsidzira, S Thomson | 1144-1145 |
| Reporting of studies based on the analysis of routinely collected health data | |
| R P Abratt, F Macbeth | 1146-1147 |
Correspondence
| COVID-19 collateral damage: Alcohol rub dermatitis as an emerging problem | |
| S M Alves, A J Arendse, S M H Kannenberg | 1148 |
| Trends in paediatric tuberculosis diagnoses in two South African hospitals early in the COVID-19 pandemic | |
| L Lebina, M Dube, K Hlongwane, H Brahmbatt, S G Lala, G Reubenson, N Martinson | 1149-1150 |
| The challenges of maintaining non-COVID medicine services at Groote Schuur Hospital, Cape Town, South Africa, during COVID-19 | |
| M Sonderup, W Spearman, I Ross, N Gogela, M Combrinck, M Setshedi, G Symons, N Wearne, S Hoosain, J-J Kruger, B Mbena, D Boayke, T Muchenje, M Masikati, E Okeyo, B Makhura, J Botha, L Hlongwane, N Ntusi | 1151 |
| The economics of poisoning: The role of telemedicine and toxicovigilance | |
| K Balme, C Stephen, L Curling, F Mohamed, C du Plessis, C Marks, V Pillay-Fuentes Lorente, R van Rensburg, G Voigt | 1152 |
Obituaries
| Martin Marivate | |
| S Moodley | 1153 |
Editorial
| Protecting healthcare workers: A critical part of the COVID-19 response | |
| L-G Bekker, S Delany-Moretlwe, B Biccard, L du Toit, L B Lovat, H-M Dehbi, R Moonesinghe, H Rees, M S Avidan | 1154-1155 |
| Access to novel therapies for COVID-19 – distributive justice and Russian roulette? | |
| M S Pepper | 1156-1157 |
In Practice
| Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease | |
| A Jaca, S Durão, J Harbron | 1158-1159 |
| Opportunities from a new disease for an old threat: Extending COVID-19 efforts to address tuberculosis in South Africa | |
| M Loveday, H Cox, D Evans, J Furin, N Ndjeka, M Osman, K Naidoo; for the National TB Think Tank 'Optimising TB Treatment Outcomes' Task Team | 1160-1167 |
| Prolonged treatment of COVID-19 pneumonia with high-flow nasal oxygen: A story of oxygen and resilience | |
| G G Audley, P Frankenfeld, S Dlamini, P Raubenheimer, J Hoare, L Cairncross, R van den Berg, M V Gule, G Calligaro | 1168-1171 |
| Age discrimination in critical care triage in South Africa: The law and the allocation of scarce health resources in the COVID-19 pandemic | |
| N Erasmus | 1172-1175 |
| Critical care triage during the COVID-19 pandemic in South Africa: A constitutional imperative! | |
| B M Morrow, P D Gopalan, I Joubert, F Paruk, A Pope | 1176-1179 |
Review
| Rapid evolution of our understanding of the pathogenesis of COVID-19: Implications for therapy | |
| F Mustafa, R Giles, M S Pepper | 1180-1185 |
Research
| The ‘ins and outs’ of colonoscopy at Wits Donald Gordon Medical Centre, South Africa: A practice audit of the outpatient endoscopy unit | |
| C Bouter, P Barrow, D Bizos, B Bobat, J Devar, N Harran, C Joseph, A Mahomed, J Oettle, J Ramos, M Seabi, G Kgabage, P Gaylard, D Surridge, H Etheredge, J Fabian, D Lutrin, K Karlsson | 1186-1190 |
| Prevalence and characteristics of incidental colorectal polyps in patients undergoing colonoscopy at a South African tertiary institution | |
| J Kruger, L Katsidzira, M Setshedi, S R Thomson | 1191-1194 |
| Postmortem lung biopsies from four patients with COVID-19 at a tertiary hospital in Cape Town, South Africa | |
| C Bruce-Brand, B W Allwood, C F N Koegelenberg, U Lalla, E Louw, A H Diacon, P T Schubert | 1195-1200 |
| The impact of COVID-19 on routine patient care from a laboratory perspective | |
| E C Kruger, R Banderker, R T Erasmus, A E Zemlin | 1201-1205 |
| Use of the antenatal antiretroviral (ARV) tracking form in maternity case records to improve ARV management | |
| T P Kerry, P G T Cudahy | 1206-1212 |
| Two-year viral load suppression among adolescents receiving antiretroviral therapy in the Cape Metropole, South Africa, 2013 - 2015: A retrospective cohort analysis | |
| B E van Wyk, E Kriel, F Mukumbang | 1213-1217 |
| Repeat injuries in childhood | |
| S M Peters, M-A Davies, A B van As | 1218-1225 |
| Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa | |
| J Jones, A Swart, E Tommy, K Cohen, A Stewart, J Voget, M Blockman | 1226-1230 |
| A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting | |
| J W Rood, R du Toit | 1231-1237 |
CPD
| CPD questions | |